![Figure 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Figure 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/7-Figure1-1.png)
Figure 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![PASI and PQOL-12 score in psoriasis : Is there any correlation? Shankar V, Ghosh S, Ghosh K, Chaudhuri U - Indian J Dermatol PASI and PQOL-12 score in psoriasis : Is there any correlation? Shankar V, Ghosh S, Ghosh K, Chaudhuri U - Indian J Dermatol](https://e-ijd.org/articles/2011/56/3/images/IndianJDermatol_2011_56_3_287_82482_f2.jpg)
PASI and PQOL-12 score in psoriasis : Is there any correlation? Shankar V, Ghosh S, Ghosh K, Chaudhuri U - Indian J Dermatol
![Efficacy and Safety of Two Doses of <i>Sphaeranthus</i><i> i</i><i>ndicus</i> Extract in the Management of Plaque Psoriasis: A Randomized, Double Blind, Placebo Controlled Phase II Trial Efficacy and Safety of Two Doses of <i>Sphaeranthus</i><i> i</i><i>ndicus</i> Extract in the Management of Plaque Psoriasis: A Randomized, Double Blind, Placebo Controlled Phase II Trial](http://article.sapub.org/image/10.5923.j.ajdv.20160501.03_002.gif)
Efficacy and Safety of Two Doses of <i>Sphaeranthus</i><i> i</i><i>ndicus</i> Extract in the Management of Plaque Psoriasis: A Randomized, Double Blind, Placebo Controlled Phase II Trial
![Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram](https://www.researchgate.net/publication/221929000/figure/fig2/AS:304724734693382@1449663446939/Psoriasis-Area-and-Severity-Index-PASI-score-assessment-H-head-LL-lower-limbs-T.png)
Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram
![Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram](https://www.researchgate.net/profile/Hugo-Oliveira-12/publication/221929000/figure/fig2/AS:304724734693382@1449663446939/Psoriasis-Area-and-Severity-Index-PASI-score-assessment-H-head-LL-lower-limbs-T_Q640.jpg)
Psoriasis Area and Severity Index (PASI) score assessment (H, head; LL,... | Download Scientific Diagram
![Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/44/4/519/F2.large.jpg)
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
![PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5e273e28-94f9-4a61-be41-3d02ba8af628/ajd13738-tbl-0001-m.jpg)
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library
![Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/8-Table3-1.png)
Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of](https://onlinelibrary.wiley.com/cms/asset/85d48eca-71ce-42ea-9c50-3f367fac9326/jdv16893-fig-0001-m.jpg)
Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of
![Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology Analysis of Body Regions and Components of PASI Scores During Adalimumab or Methotrexate Treatment for Patients With Moderate-to-Severe Psoriasis - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_2456/table1.png)